• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Proc Natl Acad Sci U S A . Impact of ADAR-induced editing of minor viral RNA populations on replication and transmission of SARS-CoV-2

tetano

Editor, Senior Moderator
Proc Natl Acad Sci U S A


. 2022 Feb 8;119(6):e2112663119.
doi: 10.1073/pnas.2112663119.
Impact of ADAR-induced editing of minor viral RNA populations on replication and transmission of SARS-CoV-2


Johan Ringlander[SUP] 1 [/SUP], Joshua Fingal[SUP] 1 [/SUP], Hanna Kann[SUP] 2 [/SUP], Kasthuri Prakash[SUP] 1 [/SUP], Gustaf Rydell[SUP] 1 [/SUP], Maria Andersson[SUP] 1 [/SUP], Anna Martner[SUP] 1 [/SUP], Magnus Lindh[SUP] 1 [/SUP], Peter Horal[SUP] 1 [/SUP], Kristoffer Hellstrand[SUP] 3 [/SUP], Michael Kann[SUP] 1 [/SUP]



Affiliations

Abstract

Adenosine deaminases acting on RNA (ADAR) are RNA-editing enzymes that may restrict viral infection. We have utilized deep sequencing to determine adenosine to guanine (A→G) mutations, signifying ADAR activity, in clinical samples retrieved from 93 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-infected patients in the early phase of the COVID-19 pandemic. A→G mutations were detected in 0.035% (median) of RNA residues and were predominantly nonsynonymous. These mutations were rarely detected in the major viral population but were abundant in minor viral populations in which A→G was more prevalent than any other mutation (P < 0.001). The A→G substitutions accumulated in the spike protein gene at positions corresponding to amino acids 505 to 510 in the receptor binding motif and at amino acids 650 to 655. The frequency of A→G mutations in minor viral populations was significantly associated with low viral load (P < 0.001). We additionally analyzed A→G mutations in 288,247 SARS-CoV-2 major (consensus) sequences representing the dominant viral population. The A→G mutations observed in minor viral populations in the initial patient cohort were increasingly detected in European consensus sequences between March and June 2020 (P < 0.001) followed by a decline of these mutations in autumn and early winter (P < 0.001). We propose that ADAR-induced deamination of RNA is a significant source of mutated SARS-CoV-2 and hypothesize that the degree of RNA deamination may determine or reflect viral fitness and infectivity.
 
Back
Top Bottom